FDA Approves Self-Administered Nasal Flu Vaccine for U.S. Consumers
The FDA has approved the first nasal spray flu vaccine for self-administration, offering a needle-free, convenient option as the U.S. prepares for the upcoming flu season.
FDA
Read More
US Advances COVID-19 Response with New Rapid Test and Vaccine Approval
The U.S. FDA approves a new at-home rapid COVID-19 test and is set to approve Moderna’s second vaccine, aiming to immunize 20 million Americans by December.